Advances and challenges in treatment of locally advanced rectal cancer. - Wikidata - wikimedia - TriplyDB

Advances and challenges in treatment of locally advanced rectal cancer.

Advances and challenges in treatment of locally advanced rectal cancer.

http://www.wikidata.org/entity/Q36025983

about

MicroRNA in rectal cancer Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer Tat-Interacting Protein 30 (TIP30) Expression Serves as a New Biomarker for Tumor Prognosis: A Systematic Review and Meta-Analysis.Sparing Sphincters and Laparoscopic Resection Improve Survival by Optimizing the Circumferential Resection Margin in Rectal Cancer Patients AEG-1 as a predictor of sensitivity to neoadjuvant chemotherapy in advanced epithelial ovarian cancer Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study.Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer.Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers.Controversies in the multimodality management of locally advanced rectal cancer.PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.Dynamic multi-echo DCE- and DSC-MRI in rectal cancer: Low primary tumor Ktrans and ΔR2* peak are significantly associated with lymph node metastasis.Recent advances in the management of rectal cancer: No surgery, minimal surgery or minimally invasive surgery.The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study.Comparative analysis focusing on surgical and early oncological outcomes of open, laparoscopy-assisted, and robot-assisted approaches in rectal cancer patients.Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy.Controversial issues in radiotherapy for rectal cancer: a systematic review.Multicentre propensity score-matched analysis of laparoscopic versus open surgery for T4 rectal cancer.Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling.Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer.Contemporary management of locally advanced rectal cancer: Resolving issues, controversies and shifting paradigms.KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer.

P2860

Q26748754-8D2CB305-C3A0-4AE9-B3E2-44D9E0AD61D3 Q26796352-75F71662-3B61-496B-9177-69D58C2536B2 Q36236282-37A7F8CB-AB75-4977-8567-57046CB56C77 Q36566955-067818D9-5292-4090-A996-5360F1D01078 Q36834096-8AAC50C4-8226-41DB-89E8-D398D6C8290F Q37227461-317F019A-EAE1-48D0-AC54-6EDE23FFC658 Q37376421-C0C8471E-E952-4BDD-A170-80BC5C86986D Q37414202-B8DB7444-424B-441D-93E9-29362202EEB5 Q38691264-37141EB8-932D-4886-A9A4-64AFC970B580 Q38863195-D149B0B4-083B-4E4D-B27C-9E566E1FA607 Q39046269-2D4697BA-672D-4ACE-BEE3-C66F3BF6EABE Q39424695-B51DA56D-A6B5-4C7C-BBE4-6486A3AF898A Q39448618-E83370F9-9313-4056-B9AF-D81948304293 Q40713772-480CFAD4-7031-43DC-A8A1-8EF67B578106 Q42321597-7255E93C-BD5E-489E-A08D-21626E5D74A2 Q47737573-4C416B37-AD9D-4EF5-B9FC-47C09C6F75EE Q48237027-066793D4-61BA-478B-80AE-6B967F090406 Q48692077-94EE108B-43BE-4898-A2C8-5C02FDBB4C36 Q50066339-778F6AB3-4CBA-4EC9-A024-76285A8BE771 Q52653160-8AF87CEB-F89C-4F4E-B31C-151CE2C876F0 Q55073830-96ECD09E-2C2A-49F0-87F5-C6ABBC46016F

P2860

Advances and challenges in treatment of locally advanced rectal cancer.

http://www.wikidata.org/entity/Q36025983

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Advances and challenges in treatment of locally advanced rectal cancer.

@ast

Advances and challenges in treatment of locally advanced rectal cancer.

@en

type

label

Advances and challenges in treatment of locally advanced rectal cancer.

@ast

Advances and challenges in treatment of locally advanced rectal cancer.

@en

prefLabel

Advances and challenges in treatment of locally advanced rectal cancer.

@ast

Advances and challenges in treatment of locally advanced rectal cancer.

@en

P1433

Q36025983-51FEA04C-604A-4513-992F-468782EDCD24

P1476

Q36025983-7BD520A9-C53B-42AB-A248-A808FC89E9DA

P2093

Q36025983-7173E888-AC43-4B5F-94EA-CF5344D6269B

P2860

Q36025983-00D07297-D3FB-4D1A-BA48-42557E878F88

Q36025983-0223F35D-25E2-4BED-BE2B-E4CABC2E30A1

Q36025983-027C1B94-D5A5-49F7-9B49-90D1560EF541

Q36025983-03553CE3-6313-414B-8A4F-EC9E5D5A0884

Q36025983-050CC657-ABBF-4034-9E1B-7B01AE7C23D5

Q36025983-0DB9096D-339B-4C86-88DE-AB03B73B4AEF

Q36025983-1518242F-4FC5-48B4-9591-191A23E1E5FB

Q36025983-15F1EAE4-513F-4111-928F-16CA94E93654

Q36025983-1667B525-CE04-48BF-8A5C-2EF304E2336D

Q36025983-16D36550-89E0-49E2-8E0F-564ADB1C7538

P304

Q36025983-BBAA224B-7A5E-43BC-BA94-375F7CB2DCD5

P31

Q36025983-06FE935D-AA5B-45CE-B2B7-0603A9805FF2

P356

Q36025983-8A1C98A7-E5B4-4D21-B91A-FC545CD6BF6B

P407

Q36025983-EF48FF48-9C35-4AA7-8F92-A5ACD43F7E7A

P433

Q36025983-37A365CD-5389-4F8D-9CB5-0BCFF8DFD5AB

P478

Q36025983-F747921E-DBAF-425B-931A-C775DBEF9431

P50

Q36025983-1E12D9F7-59A1-44E6-AEBD-62D9B9CF584A

P577

Q36025983-511409D9-93CA-45E0-B5C3-1191B31E8732

P698

Q36025983-A3CB852B-CD78-4F33-8528-65D2104275B3

P932

Q36025983-62F04A11-0F5C-46D3-9175-C955140EF4F1

P356

JCO.2014.60.1054

P1433

Journal of Clinical Oncology

P1476

Advances and challenges in treatment of locally advanced rectal cancer.

@en

P2093

Julio Garcia-Aguilar

http://www.w3.org/2001/XMLSchema#string

P2860

Postoperative adjuvant chemotherapy in rectal cancer operated for cure

Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and

Diffusion MRI for prediction of response of rectal cancer to chemoradiation.

Effective surgical adjuvant therapy for high-risk rectal carcinoma.

Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04

Preoperative staging of rectal cancer.

Extralevator abdominoperineal excision (ELAPE) for rectal cancer--short-term results from the Swedish Colorectal Cancer Registry. Selective use of ELAPE warranted.

P304

1797-1808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2014.60.1054

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Jesse Joshua Smith

P577

2015-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25918296

http://www.w3.org/2001/XMLSchema#string

P932

4559608

http://www.w3.org/2001/XMLSchema#string